Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Matthew Strobeck Insider Profile
11 Followers
Matthew Strobeck, Director at Yield10 Bioscience, holds 5.76M shares in Biodesix (Ticker: BDSX), holds 67.62K shares in QuidelOrtho (Ticker: QDEL), holds 325.24K shares in Accelerate Diagnostics (Ticker: AXDX). Most recently, Matthew Strobeck Bought ― shares of Biodesix on Nov 06, 2024 for an estimated value of 55.60K.
Profitable Transactions
9 out of 15 Profitable Transactions
Average Return
0.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Matthew Strobeck holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 20, 2020 - Mar 20, 2021
Return:+101.00%
The most profitable trade made by Matthew Strobeck
Matthew Strobeck's Trading History
Yield10 Bioscience
Jan 28, 2016
Director
Uninformative Sell
―
$1.23M
Accelerate Diagnostics
Jan 25, 2024
Director
Uninformative Buy
―
$621.20K
QuidelOrtho
May 29, 2024
Director
Uninformative Buy
―
$2.91M
Biodesix
Nov 06, 2024
Director
Informative Buy
55.60K
$8.12M
Santarus
Apr 10, 2012
―
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see Matthew Strobeck's performance on stock
You May Also Like
Matthew Strobeck insider profile FAQ
What is the percentage of profitable transactions made by Matthew Strobeck?
The percentage of profitable transactions made by Matthew Strobeck is 60%.
What is the average return per transaction made by Matthew Strobeck?
The average return per transaction made by Matthew Strobeck is 0.00%.
What stocks does Matthew Strobeck hold?
Matthew Strobeck holds: YTEN, AXDX, QDEL, BDSX, SNTS stocks.
What was Matthew Strobeck’s latest transaction?
Matthew Strobeck latest transaction was an Informative Buy of $55.60K.
What was Matthew Strobeck's most profitable transaction?
Matthew Strobeck’s most profitable transaction was an Informative Buy of AXDX stock on March 20, 2020. The return on the trade was 101.00%.
What is Matthew Strobeck's role in Yield10 Bioscience?
Matthew Strobeck's role in Yield10 Bioscience is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.